What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...

Regenxbio closes strategic partnership with Nippon Shinyaku for MPS diseases: Rockville, Maryland Wednesday, March 5, 2025, 14:00 Hrs [IST] Regenxbio Inc., a leading clinical-stag ...

REGENXBIO Inc.  today announced the closing of its previously announced strategic partnership with Nippon Shinyaku. Under the terms of the agreement, REGENXBIO and Nippon Shinyaku will develop and ...

Regenxbio (RGNX) announced the closing of its previously announced strategic partnership with Nippon Shinyaku. Under the terms of the ...

Morton was signed to a one-year deal this offseason and will be a big part of the team's plans after they lost Corbin Burnes and John Means in free agency. Furthermore, Kyle Bradish is out for ...

They’re projecting what they can do over four-plus years. Colorado receiver and defensive back Travis Hunter’s reception by the NFL community is fascinating. Evaluators offered a wide range of ...

Colorado Buffaloes two-way superstar — and the potential No. 1 pick in the 2025 NFL Draft — Travis Hunter is a one-of-one player on the football field right now, as he has played both ...

Looking for a complete list of Monster Hunter Wilds monsters? The best way for any hunter to prepare for a trip to the Forbidden Lands is to get familiar with all the monsters that call it home.

Jesus Luzardo was dominant on the mound in the Philadelphia Phillies’ 7-5 win over the Boston Red Sox on Friday. Per MLB.com’s Todd Zolecki, Luzardo stifled the Red Sox in his first taste of Spring ...

A former Limerick senior hurler is in his second day of giving evidence at the High Court over "severe" and "emasculating" injuries he sustained when he went to the aid of a co-worker who caught his ...

Denali remains on track to submit a BLA for tividenofusp alfa or DNL310 for the treatment of MPS II (Hunter syndrome), under the accelerated approval pathway in early 2025, and is preparing for a ...